Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunther Hartmann

Showing results (151-160 of 199) with videos related to

Pageof 20
Sort By:
Elife|March 3, 2016
Correction: ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional recognition of self-RNACharlotte Lässig, Sarah Matheisl, Konstantin Mj Sparrer, et al.
Clinical Drug Investigation|March 10, 2026
Recommendations on Drug Selection and Dose Adjustment for Patients with Liver Cirrhosis: Results from a Multidisciplinary Expert PanelKatharina Karsten Dafonte, Philipp Lutz, Christian Jansen, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|June 28, 2021
Detectable SARS-CoV-2 RNAemia in Critically Ill Patients, but Not in Mild and Asymptomatic InfectionsEnrico Richter, Doaa Al Arashi, Bianca Schulte, et al.
Elife|November 27, 2015
ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional recognition of self-RNACharlotte Lässig, Sarah Matheisl, Konstantin M J Sparrer, et al.
Nature Immunology|November 17, 2009
Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta productionHendrik Poeck, Michael Bscheider, Olaf Gross, et al.
BMC Family Practice|April 27, 2016
Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) - study protocol for a pragmatic randomized controlled trialJulia Carolin Stingl, Katharina Luise Kaumanns, Katrin Claus, et al.
Oncoimmunology|July 7, 2017
Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expressionJulian P Layer, Marie T Kronmüller, Thomas Quast, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 23, 2020
A continuous responder algorithm to optimize clinical management of small-cell lung cancer with progastrin-releasing peptide as a simple blood testThomas Muley, Xiaotong Zhang, Stefan Holdenrieder, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2020
Absence of cGAS-mediated type I IFN responses in HIV-1-infected T cellsCarina Elsner, Aparna Ponnurangam, Julia Kazmierski, et al.
Vaccines|May 27, 2023
Potential of Nucleic Acid Receptor Ligands to Improve Vaccination Efficacy against the Filarial Nematode <i>Litomosoides sigmodontis</i>Johanna F Scheunemann, Frederic Risch, Julia J Reichwald, et al.
Pageof 20

Showing results (151-160 of 199) with videos related to

Sort By:
Pageof 20
Elife|March 3, 2016
Correction: ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional recognition of self-RNACharlotte Lässig, Sarah Matheisl, Konstantin Mj Sparrer, et al.
Clinical Drug Investigation|March 10, 2026
Recommendations on Drug Selection and Dose Adjustment for Patients with Liver Cirrhosis: Results from a Multidisciplinary Expert PanelKatharina Karsten Dafonte, Philipp Lutz, Christian Jansen, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|June 28, 2021
Detectable SARS-CoV-2 RNAemia in Critically Ill Patients, but Not in Mild and Asymptomatic InfectionsEnrico Richter, Doaa Al Arashi, Bianca Schulte, et al.
Elife|November 27, 2015
ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional recognition of self-RNACharlotte Lässig, Sarah Matheisl, Konstantin M J Sparrer, et al.
Nature Immunology|November 17, 2009
Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta productionHendrik Poeck, Michael Bscheider, Olaf Gross, et al.
BMC Family Practice|April 27, 2016
Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) - study protocol for a pragmatic randomized controlled trialJulia Carolin Stingl, Katharina Luise Kaumanns, Katrin Claus, et al.
Oncoimmunology|July 7, 2017
Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expressionJulian P Layer, Marie T Kronmüller, Thomas Quast, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 23, 2020
A continuous responder algorithm to optimize clinical management of small-cell lung cancer with progastrin-releasing peptide as a simple blood testThomas Muley, Xiaotong Zhang, Stefan Holdenrieder, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2020
Absence of cGAS-mediated type I IFN responses in HIV-1-infected T cellsCarina Elsner, Aparna Ponnurangam, Julia Kazmierski, et al.
Vaccines|May 27, 2023
Potential of Nucleic Acid Receptor Ligands to Improve Vaccination Efficacy against the Filarial Nematode <i>Litomosoides sigmodontis</i>Johanna F Scheunemann, Frederic Risch, Julia J Reichwald, et al.
Pageof 20